Pharma Mar, S.A. (PHMMF)

Pharma Mar Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,493	1,438	816	1,238	1,175	1,606
Market Cap Growth	14.34%	76.17%	-34.05%	5.37%	-26.88%	81.25%
Enterprise Value	1,404	1,344	672	1,084	985	1,439
Last Close Price	93.00	81.07	46.26	69.39	62.50	87.30
PE Ratio	30.26	53.17	649.51	23.46	11.12	9.57
PS Ratio	6.72	7.94	4.67	5.90	4.49	4.87
PB Ratio	6.31	6.67	3.82	5.19	5.81	12.78
P/TBV Ratio	6.34	6.70	3.84	5.22	5.84	12.91
P/FCF Ratio	715.77	-	-	39.30	57.78	4.76
P/OCF Ratio	144.46	230.47	-	30.22	40.22	4.71
EV/Sales Ratio	6.37	7.42	3.84	5.17	3.77	4.36
EV/EBITDA Ratio	31.71	128.91	-	22.60	9.12	7.39
EV/EBIT Ratio	38.37	200.70	-	24.11	9.37	7.51
EV/FCF Ratio	672.99	-	-	34.42	48.46	4.26
Debt / Equity Ratio	0.26	0.25	0.23	0.19	0.28	0.55
Debt / EBITDA Ratio	1.35	4.19	48.68	0.91	0.51	0.35
Debt / FCF Ratio	28.94	-	-	1.45	2.76	0.21
Asset Turnover	0.57	0.51	0.43	0.52	0.66	1.19
Inventory Turnover	0.19	0.18	0.29	0.71	1.46	1.32
Quick Ratio	2.14	2.29	1.98	2.18	2.93	2.31
Current Ratio	2.84	3.03	2.63	2.83	3.42	2.59
Return on Equity (ROE)	21.94%	13.00%	0.55%	24.62%	66.18%	249.16%
Return on Assets (ROA)	5.91%	1.17%	-0.65%	6.91%	16.54%	43.04%
Return on Capital (ROIC)	8.30%	1.63%	-0.95%	10.67%	29.89%	77.41%
Return on Capital Employed (ROCE)	12.10%	2.40%	-	14.20%	32.80%	66.60%
Earnings Yield	3.30%	1.88%	0.15%	4.26%	8.99%	10.45%
FCF Yield	0.14%	-0.65%	-3.83%	2.54%	1.73%	21.01%
Dividend Yield	-	1.02%	1.55%	1.00%	1.18%	0.84%
Payout Ratio	-	43.71%	1028.06%	23.83%	11.71%	6.42%
Buyback Yield / Dilution	-	1.98%	0.81%	0.12%	1.31%	0.77%
Total Shareholder Return	-	3.00%	2.37%	1.12%	2.49%	1.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.